
European Startup Funding Rounds Span Biotech, Insurance and AI Security
OMass Therapeutics raises €275 million, Nauta Capital closes a new fund, and Stand and Harmonic Security secure fresh capital across Europe and the US.
AfroEuropa Newsroom
AfroEuropa desk
A series of funding announcements across Europe and the United States has drawn capital into biotech, venture investment, property insurance and enterprise AI security.
OMass Therapeutics raises €275 million
Oxford spin-out OMass Therapeutics, a UK biotech developing small-molecule treatments, closed an oversubscribed €275 million (£230 million) Series C round, according to EU-Startups. The financing was co-led by new investors Bain Capital Life Sciences, Forbion and Novo Holdings, with participation from Janus Henderson Investors, SV Health Investors and Jefferson Life Sciences. Existing backers also took part, including Syncona, Oxford Science Enterprises, GV, Northpond Ventures, Sanofi Ventures, British Business Bank and the University of Oxford.
Keep reading
European and US Tech Funding Rolls On: Nauta, LearnUpon, Goodweek and More
A wave of October 2026 deals spans a new Nauta fund, growth capital for LearnUpon, a Goodweek seed round, and raises by North.cloud, Harmonic Security and Tamr.
Other highlights
Scammer Among Biggest Victims of Tampered Ledger Wallets, Chainalysis Says
A fraudster who ran a fake online jobs scheme lost nearly $5 million in bitcoin to compromised hardware wallets, according to Chainalysis.
Follow the storyOne newsletter, two continents
The Bridge brings you the tech, startups, and leaders moving between Africa and Europe in one sharp email each morning. No spam, unsubscribe anytime.












